Updated Long-Term Survival for Patients With Metastatic Colorectal Cancer Treated With Liver Resection Followed by Hepatic Arterial Infusion and Systemic Chemotherapy

摘要

Background and Objectives: Patients who undergo liver resection for metastatic colorectal cancer (mCRC) have reported 5-year survivals ranging from 25% to 50%. The current study updated long-term survival for patients with resected liver metastases treated with adjuvant hepatic arterial infusion (HAI) and systemic (SYS) chemotherapy.